Johnson & Johnson Current Ratio 1986-2025 | JNJ
Current and historical current ratio for Johnson & Johnson (JNJ) from 1986 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Johnson & Johnson current ratio for the three months ending September 30, 2025 was 1.07.
| Johnson & Johnson Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2025-09-30 |
$54.61B |
$50.87B |
1.07 |
| 2025-06-30 |
$54.50B |
$54.18B |
1.01 |
| 2025-03-31 |
$71.55B |
$56.90B |
1.26 |
| 2024-12-31 |
$55.89B |
$50.32B |
1.11 |
| 2024-09-30 |
$53.25B |
$51.76B |
1.03 |
| 2024-06-30 |
$57.82B |
$53.93B |
1.07 |
| 2024-03-31 |
$57.00B |
$48.73B |
1.17 |
| 2023-12-31 |
$53.50B |
$46.28B |
1.16 |
| 2023-09-30 |
$53.70B |
$44.37B |
1.21 |
| 2023-06-30 |
$60.57B |
$54.17B |
1.12 |
| 2023-03-31 |
$64.39B |
$60.37B |
1.07 |
| 2022-12-31 |
$55.29B |
$55.80B |
0.99 |
| 2022-09-30 |
$65.24B |
$45.54B |
1.43 |
| 2022-06-30 |
$63.85B |
$44.82B |
1.42 |
| 2022-03-31 |
$60.42B |
$43.39B |
1.39 |
| 2021-12-31 |
$60.98B |
$45.23B |
1.35 |
| 2021-09-30 |
$59.89B |
$44.56B |
1.34 |
| 2021-06-30 |
$53.77B |
$38.72B |
1.39 |
| 2021-03-31 |
$52.53B |
$40.93B |
1.28 |
| 2020-12-31 |
$51.24B |
$42.49B |
1.21 |
| 2020-09-30 |
$57.58B |
$38.85B |
1.48 |
| 2020-06-30 |
$45.89B |
$36.77B |
1.25 |
| 2020-03-31 |
$44.23B |
$33.69B |
1.31 |
| 2019-12-31 |
$45.27B |
$35.96B |
1.26 |
| 2019-09-30 |
$44.33B |
$35.16B |
1.26 |
| 2019-06-30 |
$41.80B |
$31.35B |
1.33 |
| 2019-03-31 |
$41.99B |
$29.11B |
1.44 |
| 2018-12-31 |
$46.03B |
$31.23B |
1.47 |
| 2018-09-30 |
$47.19B |
$27.44B |
1.72 |
| 2018-06-30 |
$45.44B |
$27.49B |
1.65 |
| 2018-03-31 |
$42.77B |
$27.08B |
1.58 |
| 2017-12-31 |
$43.09B |
$30.54B |
1.41 |
| 2017-09-30 |
$41.83B |
$31.81B |
1.32 |
| 2017-06-30 |
$38.79B |
$28.87B |
1.34 |
| 2017-03-31 |
$63.35B |
$25.12B |
2.52 |
| 2016-12-31 |
$65.03B |
$26.29B |
2.47 |
| 2016-09-30 |
$63.32B |
$23.23B |
2.73 |
| 2016-06-30 |
$66.29B |
$21.54B |
3.08 |
| 2016-03-31 |
$62.74B |
$22.13B |
2.83 |
| 2015-12-31 |
$60.21B |
$27.75B |
2.17 |
| 2015-09-30 |
$63.49B |
$25.26B |
2.51 |
| 2015-06-30 |
$61.00B |
$24.51B |
2.49 |
| 2015-03-31 |
$58.19B |
$23.84B |
2.44 |
| 2014-12-31 |
$55.74B |
$25.03B |
2.23 |
| 2014-09-30 |
$59.97B |
$22.98B |
2.61 |
| 2014-06-30 |
$60.12B |
$24.36B |
2.47 |
| 2014-03-31 |
$57.37B |
$23.84B |
2.41 |
| 2013-12-31 |
$56.41B |
$25.68B |
2.20 |
| 2013-09-30 |
$52.18B |
$25.84B |
2.02 |
| 2013-06-30 |
$51.27B |
$23.77B |
2.16 |
| 2013-03-31 |
$47.23B |
$22.52B |
2.10 |
| 2012-12-31 |
$46.12B |
$24.26B |
1.90 |
| 2012-09-30 |
$44.79B |
$23.94B |
1.87 |
| 2012-06-30 |
$41.62B |
$23.85B |
1.75 |
| 2012-03-31 |
$57.01B |
$21.20B |
2.69 |
| 2011-12-31 |
$54.32B |
$22.81B |
2.38 |
| 2011-09-30 |
$53.44B |
$21.69B |
2.46 |
| 2011-06-30 |
$52.67B |
$20.99B |
2.51 |
| 2011-03-31 |
$49.22B |
$24.01B |
2.05 |
| 2010-12-31 |
$47.31B |
$23.07B |
2.05 |
| 2010-09-30 |
$42.72B |
$17.41B |
2.45 |
| 2010-06-30 |
$39.02B |
$17.16B |
2.27 |
| 2010-03-31 |
$38.86B |
$18.50B |
2.10 |
| 2009-12-31 |
$39.54B |
$21.73B |
1.82 |
| 2009-09-30 |
$35.60B |
$19.25B |
1.85 |
| 2009-06-30 |
$35.49B |
$19.89B |
1.79 |
| 2009-03-31 |
$34.84B |
$21.33B |
1.63 |
| 2008-12-31 |
$34.38B |
$20.85B |
1.65 |
| 2008-09-30 |
$36.59B |
$22.73B |
1.61 |
| 2008-06-30 |
$35.82B |
$21.78B |
1.64 |
| 2008-03-31 |
$33.82B |
$22.07B |
1.53 |
| 2007-12-31 |
$29.95B |
$19.84B |
1.51 |
| 2007-09-30 |
$28.94B |
$19.33B |
1.50 |
| 2007-06-30 |
$25.80B |
$18.98B |
1.36 |
| 2007-03-31 |
$24.67B |
$19.66B |
1.26 |
| 2006-12-31 |
$22.98B |
$19.16B |
1.20 |
| 2006-09-30 |
$31.29B |
$12.06B |
2.59 |
| 2006-06-30 |
$31.51B |
$12.19B |
2.59 |
| 2006-03-31 |
$33.75B |
$13.19B |
2.56 |
| 2005-12-31 |
$31.48B |
$12.64B |
2.49 |
| 2005-09-30 |
$30.58B |
$12.05B |
2.54 |
| 2005-06-30 |
$28.72B |
$11.64B |
2.47 |
| 2005-03-31 |
$28.77B |
$12.98B |
2.22 |
| 2004-12-31 |
$27.32B |
$13.93B |
1.96 |
| 2004-09-30 |
$26.82B |
$12.33B |
2.18 |
| 2004-06-30 |
$24.66B |
$12.06B |
2.04 |
| 2004-03-31 |
$24.36B |
$12.45B |
1.96 |
| 2003-12-31 |
$23.00B |
$13.45B |
1.71 |
| 2003-09-30 |
$22.15B |
$12.78B |
1.73 |
| 2003-06-30 |
$21.38B |
$12.84B |
1.67 |
| 2003-03-31 |
$20.47B |
$11.46B |
1.79 |
| 2002-12-31 |
$19.27B |
$11.45B |
1.68 |
| 2002-09-30 |
$19.00B |
$10.70B |
1.78 |
| 2002-06-30 |
$18.85B |
$10.57B |
1.78 |
| 2002-03-31 |
$18.42B |
$8.30B |
2.22 |
| 2001-12-31 |
$18.47B |
$8.04B |
2.30 |
| 2001-09-30 |
$19.08B |
$7.50B |
2.54 |
| 2001-06-30 |
$18.19B |
$7.35B |
2.48 |
| 2001-03-31 |
$16.42B |
$6.82B |
2.41 |
| 2000-12-31 |
$16.69B |
$7.26B |
2.30 |
| 2000-09-30 |
$15.23B |
$6.67B |
2.28 |
| 2000-06-30 |
$14.37B |
$6.61B |
2.18 |
| 2000-03-31 |
$13.98B |
$7.13B |
1.96 |
| 1999-12-31 |
$13.20B |
$7.45B |
1.77 |
| 1999-09-30 |
$12.86B |
$6.98B |
1.84 |
| 1999-06-30 |
$12.15B |
$7.89B |
1.54 |
| 1999-03-31 |
$11.62B |
$7.87B |
1.48 |
| 1998-12-31 |
$11.13B |
$8.16B |
1.36 |
| 1998-09-30 |
$12.18B |
$5.40B |
2.26 |
| 1998-06-30 |
$11.34B |
$5.14B |
2.21 |
| 1998-03-31 |
$11.13B |
$5.22B |
2.14 |
| 1997-12-31 |
$10.56B |
$5.28B |
2.00 |
| 1997-09-30 |
$11.14B |
$5.48B |
2.03 |
| 1997-06-30 |
$10.27B |
$5.31B |
1.93 |
| 1997-03-31 |
$9.97B |
$5.45B |
1.83 |
| 1996-12-31 |
$9.37B |
$5.18B |
1.81 |
| 1996-09-30 |
$9.60B |
$4.93B |
1.95 |
| 1996-06-30 |
$9.24B |
$4.40B |
2.10 |
| 1996-03-31 |
$9.00B |
$4.42B |
2.04 |
| 1995-12-31 |
$7.94B |
$4.39B |
1.81 |
| 1995-09-30 |
$8.08B |
$4.31B |
1.88 |
| 1995-06-30 |
$7.84B |
$4.29B |
1.83 |
| 1995-03-31 |
$7.56B |
$4.17B |
1.81 |
| 1994-12-31 |
$6.68B |
$4.27B |
1.57 |
| 1994-09-30 |
$6.66B |
$4.41B |
1.51 |
| 1994-06-30 |
$6.12B |
$3.20B |
1.91 |
| 1994-03-31 |
$5.67B |
$3.15B |
1.80 |
| 1993-12-31 |
$5.22B |
$3.21B |
1.62 |
| 1993-09-30 |
$5.64B |
$3.34B |
1.69 |
| 1993-06-30 |
$5.58B |
$3.04B |
1.84 |
| 1993-03-31 |
$5.43B |
$3.15B |
1.73 |
| 1992-12-31 |
$5.42B |
$3.43B |
1.58 |
| 1992-09-30 |
$5.90B |
$3.29B |
1.80 |
| 1992-06-30 |
$5.45B |
$3.35B |
1.63 |
| 1992-03-31 |
$4.95B |
$2.76B |
1.79 |
| 1991-12-31 |
$4.93B |
$2.69B |
1.84 |
| 1991-09-30 |
$4.76B |
$2.39B |
1.99 |
| 1991-06-30 |
$4.60B |
$2.53B |
1.82 |
| 1991-03-31 |
$4.55B |
$2.30B |
1.98 |
| 1990-12-31 |
$4.66B |
$2.62B |
1.78 |
| 1990-09-30 |
$4.91B |
$2.92B |
1.68 |
| 1990-06-30 |
$4.68B |
$2.82B |
1.66 |
| 1990-03-31 |
$4.19B |
$2.57B |
1.63 |
| 1989-12-31 |
$3.78B |
$1.93B |
1.96 |
| 1989-09-30 |
$3.75B |
$1.84B |
2.04 |
| 1989-06-30 |
$3.86B |
$2.12B |
1.82 |
| 1989-03-31 |
$3.68B |
$1.94B |
1.90 |
| 1988-12-31 |
$3.50B |
$1.87B |
1.88 |
| 1988-09-30 |
$3.50B |
$2.16B |
1.62 |
| 1988-06-30 |
$3.75B |
$2.24B |
1.68 |
| 1988-03-31 |
$3.66B |
$2.00B |
1.83 |
| 1987-12-31 |
$3.27B |
$1.76B |
1.86 |
| 1987-09-30 |
$3.64B |
$2.14B |
1.70 |
| 1987-06-30 |
$3.47B |
$2.54B |
1.37 |
| 1987-03-31 |
$3.22B |
$2.42B |
1.33 |
| 1986-12-31 |
$3.20B |
$2.29B |
1.40 |
| 1985-12-31 |
$2.90B |
$1.17B |
2.47 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$450.090B |
$94.943B |
|
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|
